Upon electronic submission of the manuscript, all authors must declare their conflicts of interest, which encompass possible involvement with the device or pharmaceutical industries, in the previous 2 years, related to percutaneous intervention in cardiac, peripheral, and cerebrovascular diseases.
If there are no conflicts of interest, this condition must also be declared.